Prevalence of viral hepatitis and molecular analysis of HBV among voluntary blood donors in west Iran

New Microbiologica

Volumn 32, Issue 2, 2009, Pages 193-198

  Doosti, Abbas ^a   Arnini Bavil Olyaee, Samad ^b   Tajbakhsh, Elaheh ^a   Adeli, Ahmad ^b   Mahboudi, Fereidoun ^b  

^a ISLAMIC AZAD UNIVERSITY   (Iran)

^b PASTEUR INSTITUTE OF IRAN   (Iran)

Author keywords

Blood donors; HBV; HCV; HDV; Iran; Seromolecular survey

Indexed keywords

VIRUS DNA;

ADOLESCENT; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; BLOOD; BLOOD DONOR; EPIDEMIOLOGY; FEMALE; GENETICS; HEPATITIS B VIRUS; HEPATITIS C VIRUS; HEPATITIS DELTA VIRUS; HUMAN; IRAN; ISOLATION AND PURIFICATION; MALE; MIDDLE AGED; PHYLOGENY; STRUCTURAL GENE; VIROLOGY; VIRUS HEPATITIS;

ADOLESCENT; ADULT; BLOOD DONORS; DNA, VIRAL; DRUG RESISTANCE, VIRAL; FEMALE; GENES, POL; HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS DELTA VIRUS; HEPATITIS, VIRAL, HUMAN; HUMANS; IRAN; MALE; MIDDLE AGED; PHYLOGENY; SEROEPIDEMIOLOGIC STUDIES;

HEPATITIS B VIRUS; HEPATITIS C VIRUS;

EID: 67649963664     PISSN: 11217138     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (35)

1. AFZALI H., ARDAKANI T.A., VALI G.R. (2001). Seroepidemiology of hepatitis B and C in blood donors in Kashan. Feyz. 23, 43-50.
2. AL TRAIF I., ALI A., DAFALLA M., AL TAMIMI W., QASSEM L. (2004). Prevalence of hepatitis delta antibody among HBsAG carriers in Saudi Arabia. Ann. Saudi Med. 24, 343-344.
3. ALAVIAN S.M. (2007a). Control of hepatitis C in Iran: vision and missions. Hep. Mon. 7, 57-58.
4. ALAVIAN S.M. (2007b). Ministry of health in Iran is serious about controlling hepatitis B. Hep. Mon. 7, 3-5.
5. ALAVIAN S.M., ALAVIAN S.H. (2005). Hepatitis delta virus infection: Iran, Middle East and Central Asia. Hep. Mon. 5, 137-143.
6. AMEEN R., SANAD N., AL SHEMMARI S., SIDDIQUE I., CHOWDHURY R.I., AL HAMDAN S., AL BASHIR A. (2005). Prevalence of viral markers among first- time Arab blood donors in Kuwait. Transfusion. 45, 1973-1980.
7. AMINI-BAVIL-OLYAEE S., ALAVIAN S.M., ADELI A., SARRAMI- FOROOSHANI R., SABAHI F., SABOURI E., TAVANGAR H.R., AZIZI M., MAHBOUDI F. (2006). Hepatitis B virus genotyping, core promoter, and precore/core mutations among Afghan patients infected with hepatitis B: a preliminary report. J. Med. Virol. 78, 358-364.
8. AMINI-BAVIL-OLYAEE S., HOSSEINI S.Y., SABAHI E, ALAVIAN S.M. (2008). Hepatitis B virus (HBV) genotype and YMDD motif mutation profile among patients infected with HBV and untreated with lamivudine. Int. J. Infect. Dis. 12, 83-87.
9. AMINI-BAVIL-OLYAEE S., SARRAMI- FOROOSHANI R., MAHBOUDI F, SABAHI F, ADELI A., NOORINAYER B., AZIZI M., REZA Z.M. (2005). Genotype characterization and phylogenetic analysis of hepatitis B virus isolates from Iranian patients. J. Med. Virol. 75, 227- 234.
10. DEHESA-VIOLANTE M., NUNEZ-NATERAS R. (2007). Epidemiology of hepatitis virus B and C. Arch. Med. Res. 38, 606-611.
11. ENOMOTO M., TAMORI A., NISHIGUCHI S. (2006) Hepatitis B virus genotypes and response to antiviral therapy. Clin. Lab. 52, 43-47.
12. FARCI P. (2006). Treatment of chronic hepatitis D: new advances, old challenges. Hepatology. 44, 536-539.
13. FARZADEGAN H., HARBOUR C, ALA F. (1979). The prevalence of hepatitis B surface antigen and its antibody in blood donors and high risk groups in Iran. Vox. Sang. 37, 182-186.
14. GHAVANINI A.A., SABRI M.R. (2000). Hepatitis B surface antigen and anti-hepatitis C antibodies among blood donors in the Islamic Republic of Iran. East. Mediterr. Health. J. 6, 1114-1116.
15. GUROL E., SABAN C, ORAL O., CIGDEM A., ARMAGAN A. (2006). Trends in hepatitis B and hepatitis C virus among blood donors over 16 years in Turkey. Eur. J. Epidemiol. 21, 299-305.
16. KHAN Z.A., ASLAM M.I., ALI S. (2007). The frequency of hepatitis B and C among volunteer blood donors in Balochistan. Hep. Mon. 7, 73-76.
17. KIDD-LJUNGGREN K., MYHRE E., BLACKBERG J. (2004). Clinical and serological variation between patients infected with different Hepatitis B virus genotypes. J. Clin. Microbiol. 42, 5837-5841.
18. KOBAYASHI S., IDE T., SATA M. (2001). Detection of YMDD motif mutations in some lamivudine-un- treated asymptomatic hepatitis B virus carriers. J. Hepatol. 34, 584-586.
19. KUMAR S., TAMURA K., NEI M. (2004). MEGA3: Integrated software for molecular evolutionary genetics analysis and sequence alignment. Brief. Bioinfortn. 5, 150-163.
20. LIU C.J., CHEN D.S., CHEN RJ. (2006). Epidemiology of HBV infection in Asian blood donors: emphasis on occult HBV infection and the role of NAT. J. Clin. Virol. 36 (1), S33-S44.
21. MAHMOODIAN-SHOOSHTARI M., POURFATHOLLAH A. (2006). An overview analysis of blood donation in the Islamic Republic of Iran. Arch. Iran Med. 9, 200- 203.
22. MEDICI M.C., ALOISI A., MARTINELLI M., ABELLI L.A., CASULA E, VALCAVI P., DETTORI G., CHEZZI C. (2006). HBV genotypes and antiviral-resistant variants in HBV infected subjects in Northern Italy. New Microbiol. 29, 63-67.
23. MERAT S., MALEKZADEH R., REZVAN H., KHATIBIAN M. (2000). Hepatitis B in Iran. Arch. Iran Med. 3, 192- 201.
24. MOHEBBI S.R., ZALI N., DERAKHSHAN E, TAHAMI A., MASHAYEKHI R., AMINI-BAVIL- OLYAEE S., ZALI M.R. (2008). Molecular epidemiology of hepatitis delta virus (HDV) in Iran: a preliminary report. J. Med. Virol. 80, 2092-2099.
25. MONIRI R., MOSAYEBII Z., MOSSAVI G.A. (2004). Seroprevalence of Cytomegalovirus, hepatitis B, hepatitis C and human immunodeficiency virus antibodies among volunteer blood donors. Iran J. Publ. Health. 33, 38-42.
26. NABAVIZADEH S.H., HAGHBEEN S. (2000). Prevalence of transmitted infection in donors of Yasuji blood transfusion organization. J. Guilan. Univ. Med. Sci. 36, 64-67.
27. PANHOTRA B.R., AL BAHRANI A., UL-HASSAN Z. (2005). Epidemiology of antibody to hepatitis B core antigen screening among blood donors in Eastern Saudi Arabia. Need to replace the test by HBV DNA testing. Saudi Med. J. 26, 270-273.
28. QIRBI N., HALL A.J. (2001). Epidemiology of hepatitis B virus infection in the Middle East. East. Mediterr. Health. J. 7, 1034-1045.
29. REZVAN H., FOROUZANDEH B., TAROYAN S., FADAIEE S., AZORDEGAN F. (1990). A study on delta virus infection and its clinical impact in Iran. Infection. 18, 26-28.
30. SADEGHI A., SHARIATZADEH M.R., LAMEI A. (1998). Evaluation of hepatitis C virus (HCV) among blood donors in Urmia Transfusion Center. Urtnia Med. J. 4, 242-248.
31. SAMIMI-RAD K., NATEGH R., MALEKZADEH R., NORDER H., MAGNIUS L. (2004). Molecular epidemiology of hepatitis C virus in Iran as reflected by phylogenetic analysis of the NS5B region. J. Med. Virol. 74, 246- 252.
32. SERTOZ R.Y., ERENSOY S., PAS S., OZACAR T., NIESTERS H. (2008). Restriction fragment length polymorphism analysis and direct sequencing for determination of HBV genotypes in a Turkish population. New Microbiol. 31, 189-194.
33. THIBAULT V, AUBRON-OLIVIER C, AGUT H., KATLAMA C. (2002). Primary infection with a lamivudine-resist- ant hepatitis B virus. AIDS. 16, 131-133.
34. VAHID T., ALAVIAN S.M., KABIR A., KAFAEE J., YEKTAPARAST B. (2005). Hepatitis B prevalence and risk factor in blood donors in Ghazvin, IR. Iran. Hep. Mon. 5, 117-122.
35. VERSCHUERE V, YAP P.S., FEVERY J. (2005). Is HBV geno- typing of clinical relevance? Acta Gastroenterol. Belg. 68, 233-236.